Allen Wan
Bloomberg News bureau chief in Shenzhen whose reporting and on-air analysis focuses on China’s technology sector, including semiconductors, Huawei, U.S. sanctions, domestic chipmaking efforts, and China’s AI infrastructure ambitions.
China’s Brain-Chip Startups Race Toward Commercial Medical Use
Bloomberg Primer reports on the race to commercialize brain-computer interfaces through NeuroXess, a Shanghai startup testing an implanted device in a paralyzed patient. The source presents BCI less as near-term human enhancement than as an assistive medical technology still facing safety, regulatory and reimbursement tests, while arguing that China’s policy support could help its companies compete with better-funded US rivals.
China Is Betting on Megaregions to Escape the Middle-Income Trap
Bloomberg’s documentary argues that Hong Kong’s Northern Metropolis is not just a local development plan but a test case for China’s attempt to turn megaregions into a new growth engine. The project would convert rural land near Shenzhen into a technology hub linking Hong Kong more tightly to the mainland’s Greater Bay Area, an 11-city, $2tn economy. The source presents the strategy as a bid to escape slower growth through concentration of people, capital and ideas, while showing the displacement, political constraints and institutional frictions that come with it.
AI Demand Is Stress-Testing the Global Semiconductor Supply Chain
Bloomberg’s primer argues that the AI boom is turning the semiconductor supply chain into a strategic stress test, raising demand for advanced processors while exposing how dependent the industry remains on a handful of companies, machines and manufacturing clusters. The source traces that pressure through ASML’s lithography tools, AMD’s AI chip designs, TSMC’s concentration of advanced fabrication in Taiwan, and competing US and Chinese efforts to rebuild domestic capacity. Its central claim is that chips are becoming more economically and politically essential just as their production remains physically fragile, capital-intensive and difficult to replicate.